Cargando…
Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
Systemic sclerosis (SSc) is a complicated multisystem disease which is characterized by the highest standardized mortality ratio among all systemic rheumatic diseases with no approved therapies so far. From a pathogenetic point of view it is generally considered that autoimmunity, vasculopathy and f...
Autores principales: | Daoussis, Dimitrios, Liossis, Stamatis-Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045920/ https://www.ncbi.nlm.nih.gov/pubmed/32185340 http://dx.doi.org/10.31138/mjr.30.1.33 |
Ejemplares similares
-
Calcified lymph nodes and systemic sclerosis
por: Angelopoulou, Fotini, et al.
Publicado: (2018) -
B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence
por: Daoussis, Dimitrios, et al.
Publicado: (2011) -
B cells tell scleroderma fibroblasts to produce collagen
por: Daoussis, Dimitrios, et al.
Publicado: (2013) -
Dkk1: A key molecule in joint remodelling and fibrosis
por: Klavdianou, Kalliopi, et al.
Publicado: (2017) -
B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin
por: Daoussis, Dimitrios, et al.
Publicado: (2012)